Skip to main content
HSTMHealthStream, Inc.Sell4.9·$26.29
SellModerate Confidence
Investment thesis

HSTM combines a consistent earnings-beat track record and excellent cash conversion with a rich valuation, elevated leverage, and a negative risk-reward asymmetry now that its price target has effectively been reached.

Thesis pillars

  • Strong Earnings Beat Track Record→Stable
  • Excellent Cash Conversion Quality→Stable
  • Rich Valuation With Limited Upside↑Improving
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 5, 2026, based on the 10-K filed Feb 27, 2026· older than 90 days

Full reasoning →

Open full analysis

HealthStream, Inc. (HSTM) Stock Analysis

SellVALUE-TRAP 1/5QualityShortModerate Confidence

Healthcare · Health Information Services

Sell if holding. At $26.29, A.R:R 1.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: healthcare industry; Weak overall score: 4.9/10.

HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning and compliance training, clinical competency development, staff scheduling, and credentialing/privileging through its hStream technology platform. The company,... Read more

$26.29+16.4% A.UpsideScore 4.9/10#20 of 22 Health Information Services
QualityF-score7 / 9FCF yield6.61%
IncomeYield0.53%Payout19.43%sustainable
Stop $25.23Analyst target $30.60(−15% haircut)A.R:R 1.4:1
Analyst consensus$36.00+36.9%3 analysts with price targets
$30.60Analyst target
$26.29price
$36.00mean
$40

Sell if holding. At $26.29, A.R:R 1.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: healthcare industry; Weak overall score: 4.9/10. Chart setup: No clear chart pattern; technical signals are mixed. Score 4.9/10, moderate confidence.

Passes 4/8 gates (news events none recent, earnings proximity 92d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and clean insider activity. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

No fresh coverage since Oct 31, 2026

Recent Developments — HealthStream, Inc.

Latest item Oct 31, 2026 · Generated 2026-11-22T12:02:08Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Feb 22, 202792d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.8
Strong earnings beat streak (3/4)
Risks
Concentration risk — Customer: healthcare industry
Weak overall score: 4.9/10
Weak growth

Key Metrics

P/E (TTM)37.6
P/E (Fwd)28.6
Mkt Cap$804M
EV/EBITDA15.8
Profit Mgn6.2%
ROE5.5%
Rev Growth8.9%
Beta0.43
Dividend0.53%
Analysts with ratings12

Quality Signals

Piotroski F7/9MoatNarrow

Options Flow

P/C0.15bullish
IV69%elevated

Concentration Risks(10-K Item 1A)

  • HIGHCustomerhealthcare industry
    10-K Item 1A: 'our lack of market diversification resulting from our concentration on the healthcare industry may make us susceptible to losing market share to our competitors'
  • MEDIUMCustomerhealthcare provider customers
    10-K Item 1: 'We derive a substantial portion of our revenues from a relatively small number of customers that are healthcare providers.'

Material Events(8-K, last 90d)

  • 2026-05-08Item 5.02LOW
    Michael M. Collier was promoted to Chief Operating Officer and EVP from EVP, Corporate Strategy, Development & Operations, effective May 4, 2026, and granted options for 18,781 shares. Routine promotion, not a departure.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
4.7

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Obv
1.0
Volume
2.6
Ma Position
4.0
Rsi
9.3
Oversold in uptrend (RSI 10)Volume distribution (falling OBV)Above 200-day MA
GatesMomentum 3.4<4.5A.R:R 1.4 < 1.5@spotINSIDER 0.73%=EXTREMEExecutive change: officer departure/appointmentNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 92d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
10 · Oversold
↓ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $26.01Resistance $35.56

Price Targets

$25
$31
A.Upside+16.4%
A.R:R1.4:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeCrisis

Risk Alerts

! momentum at 3.4 (below the engine's 4.5 threshold)
! asymmetry at 1.4 (below the engine's 1.5 threshold)@spot
! Insider activity: 0.73%=extreme

Earnings

B
B
B
M
3/4 beats
Next Earnings2027-02-22 (92d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HSTM stock a buy right now?

Sell if holding. At $26.29, A.R:R 1.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: healthcare industry; Weak overall score: 4.9/10. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $25.23. Score 4.9/10, moderate confidence.

What is the HSTM stock price target?

Analyst target: $30.60 (+16.4% upside). Prior stop was $25.23. Stop-loss: $25.23.

What are the risks of investing in HSTM?

Concentration risk — Customer: healthcare industry; Weak overall score: 4.9/10; Weak growth.

Is HSTM overvalued or undervalued?

HealthStream, Inc. trades at a P/E of 37.6 (forward 28.6). TrendMatrix value score: 5.1/10. Verdict: Sell.

What do analysts say about HSTM?

12 analysts rate HSTM, with a consensus score of 3.8/5. 3 analysts publish price targets averaging $36.

What does HealthStream, Inc. do?HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning...

HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning and compliance training, clinical competency development, staff scheduling, and credentialing/privileging through its hStream technology platform. The company, organized as a single reportable segment since 2023, derives a substantial portion of its subscription-based revenue from a relatively small number of healthcare-provider customers, though no single customer exceeded 10% of 2025 revenue, and has grown through acquisitions including Virsys12 and MissionCare Collective in 2

Related stocks: WAY (Waystar Holding Corp.) · OMDA (Omada Health, Inc.) · CTEV (Claritev Corporation) · EVH (Evolent Health, Inc) · HTFL (Heartflow, Inc.)
Home › Stocks › HSTM

Latest news

Latest News

TradingKey116d ago
GuruFocus109d ago
MarketBeat109d ago
Tradingkey.com117d ago
GuruFocus124d agoAnalyst
MarketBeat110d ago
TipRanks110d ago
GuruFocus110d ago
GuruFocus110d ago
Dars.gov.et115d ago
TradingKey115d ago
TradingKey115d ago
Yahoo Finance122d agoAnalyst
Moomoo122d agoEarnings
GuruFocus123d ago
MarketBeat112d ago
MarketBeat22d ago
Simply Wall St22d ago
TradingKey120d ago
TradingView29d agoEarnings
Loading more...